HomeAI · summaries
Storia in 3 fonti
Why Is Unicycive Therapeutics Stock Falling Tuesday? - Unicycive Therapeutics (NASDAQ:UNCY)
Unicycive Therapeutics ($UNCY) stock crashes over 46% as FDA rejects kidney disease drug NDA again over third-party manufacturing issues.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Unicycive gets second CRL for kidney drug as manufacturing woes continue
Unicycive's CKD drug oxylanthanum carbonate gets a second FDA rejection over third-party manufacturing issues; shares drop ~50% premarket.
- ·
fiercepharma.com
Unicycive turned away by FDA again over manufacturer’s plant shortfalls
After Unicycive Therapeutics had its drug application for oxylanthanum carbonate (OLC)
- ·
benzinga.com
Why Is Unicycive Therapeutics Stock Falling Tuesday? - Unicycive Therapeutics (NASDAQ:UNCY)
Unicycive Therapeutics ($UNCY) stock crashes over 46% as FDA rejects kidney disease drug NDA again over third-party manufacturing issues.